Feb 24, 2026 12:02PM
Feb 11, 2026 04:05PM
Feb 5, 2026 06:22AM
Feb 5, 2026 06:20AM
Jan 29, 2026 12:01PM
Jan 29, 2026 12:00PM
Jan 21, 2026 12:02PM AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
Jan 12, 2026 04:05PM
Jan 7, 2026 12:03PM
Jan 7, 2026 12:02PM
Dec 22, 2025 11:57AM
Dec 18, 2025 01:17PM
Dec 15, 2025 12:39PM
Dec 11, 2025 12:29PM AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
Dec 10, 2025 04:07PM
Dec 10, 2025 04:05PM
Nov 11, 2025 04:05PM
Nov 11, 2025 04:05PM
Oct 23, 2025 06:21AM
Oct 23, 2025 06:20AM
Oct 16, 2025 02:58PM AB Science shares initial phase 1 data for AB8939-venetoclax combination
Oct 16, 2025 02:57PM
Oct 14, 2025 02:36AM
Oct 14, 2025 02:36AM
Oct 10, 2025 12:10PM
Oct 9, 2025 04:05PM
Sep 30, 2025 12:32PM
Sep 10, 2025 04:07PM AllianceBernstein reports August assets under management at $844 billion
Sep 10, 2025 04:05PM
Aug 18, 2025 09:51AM
Aug 11, 2025 04:05PM
Jul 30, 2025 01:45AM
Jul 24, 2025 06:21AM
Jul 24, 2025 06:20AM
Jul 24, 2025 01:57AM AB Science receives European approvals for phase 3 ALS study
Jul 24, 2025 01:56AM
Jul 10, 2025 04:07PM
Jul 10, 2025 04:05PM
Jul 4, 2025 02:01AM
Jun 30, 2025 02:03AM
Jun 23, 2025 02:03AM
Jun 12, 2025 01:59AM AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036
Jun 10, 2025 04:06PM
Jun 10, 2025 04:05PM
May 15, 2025 02:07AM
May 12, 2025 04:05PM
May 12, 2025 04:05PM
May 12, 2025 02:14AM
May 5, 2025 12:03PM AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting
May 1, 2025 04:06AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All